Adrenergic and calcium modulation of the heart in stress: From molecular biology to function

References

• Axelrod J. Factors affecting the metabolism of epinephrine and other amines. Res Publ Assoc Res Nerv Ment Dis 1962; 40: 280–287
   PubMedGoogle Scholar
• Beckers F, Ramaekers D, Speijer G, Ector H, Vanhaecke J, Verheyden B, Van Cleemput J, Droogne W, Van de Werf F, Aubert AE. Different evolutions in heart rate variability after heart transplantation: 10-year follow-up. Transplantation 2004; 78: 1523–1531
   PubMed Web of Science ®Google Scholar
• Berkowitz DE, Price DT, Bello EA, Page SO, Schwinn DA. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology 1994; 81: 1235–1244
   PubMed Web of Science ®Google Scholar
• Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 2003; 5: 1051–1061
   PubMed Web of Science ®Google Scholar
• Bohn MC, Goldstein M, Black IB. Role of glucocorticoids in expression of the adrenergic phenotype in rat embryonic adrenal gland. Dev Biol 1981; 82: 1–10
   PubMed Web of Science ®Google Scholar
• Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51: 651–690
   PubMed Web of Science ®Google Scholar
• Bruhn TO, Sutton RE, Rivier CL, Vale WW. Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. Neuroendocrinology 1984; 39: 170–175
   PubMed Web of Science ®Google Scholar
• Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Jr., Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994; 46: 121–136
   PubMed Web of Science ®Google Scholar
• Chen XH, Harden KT, Nicholas RA. Molecular cloning and characterization of a novel β-adrenergic receptor. J Biol Chem 1994; 269: 24810–24819
   PubMed Web of Science ®Google Scholar
• Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132: 38–42
   PubMed Web of Science ®Google Scholar
• Culman J, Torda T, Weise VK. A radiometric assay for phenylethanolamine N-methyltransferase and catechol O-methyltransferase in a single tissue sample: Application to rat hypothalamic nuclei, pineal gland, and heart. Anal Biochem 1987; 164: 345–354
   PubMed Web of Science ®Google Scholar
• Deelman LE, Jonk LJ, Henning RH. The isolation and characterization of the promoter of the human type 1 inositol 1,4,5-trisphosphate receptor. Gene 1998; 207: 219–225
   PubMed Web of Science ®Google Scholar
• De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ. Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: Effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 2002; 26: 1442–1450
   PubMed Web of Science ®Google Scholar
• Docherty JR. Age-related changes in adrenergic neuroeffector transmission. Auton Neurosci 2002; 96: 8–12
   PubMed Web of Science ®Google Scholar
• Ebert SN, Thompson RP. Embryonic epinephrine synthesis in the rat heart before innervation: Association with pacemaking and conduction tissue development. Circ Res 2001; 88: 117–124
   Google Scholar
• Ebert SN, Baden JM, Mathers LH, Siddall BJ, Wong DL. Expression of phenylethanolamine n-methyltransferase in the embryonic rat heart. J Mol Cell Cardiol 1996; 28: 1653–1658
   PubMed Web of Science ®Google Scholar
• Ecker PM, Lin CC, Powers J, Kobilka BK, Dubin AM, Bernstein D. Effect of targeted deletions of beta1- and beta2-adrenergic-receptor subtypes on heart rate variability. Am J Physiol Heart Circ Physiol 2006; 290: H192–H199
   PubMed Web of Science ®Google Scholar
• Elayan HH, Kennedy B, Ziegler MG. Epinephrine synthesis by an N-methyltransferase in rat liver. Gastroenterology 1990a; 98: 152–155
   PubMed Web of Science ®Google Scholar
• Elayan HH, Kennedy BP, Ziegler MG. Cardiac atria and ventricles contain different inducible adrenaline synthesising enzymes. Cardiovasc Res 1990b; 24: 53–56
   PubMedGoogle Scholar
• Endoh M, Hiramoto T, Ishihata A, Takanashi M, Inui J. Myocardial alpha 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ Res 1991; 68: 1179–1190
   PubMed Web of Science ®Google Scholar
• Esler M, Eisenhofer G, Dart A, Chin J, Cox H, Lambert G, Jennings G. Adrenaline release by the human heart. Clin Exp Pharmacol Physiol 1991; 18: 67–70
   PubMed Web of Science ®Google Scholar
• Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions. Physiol Rev 1990; 70: 963–985
   PubMed Web of Science ®Google Scholar
• Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Opin Cell Biol 1995; 7: 825–834
   PubMed Web of Science ®Google Scholar
• Farah VM, Joaquim LF, Morris M. Stress cardiovascular/autonomic interactions in mice. Physiol Behav 2006, (in press)
   PubMed Web of Science ®Google Scholar
• Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: Implications for alpha1-adrenoceptor classification. Br J Pharmacol 1997; 121: 1127–1135
   PubMed Web of Science ®Google Scholar
• Fukunaga S, Setoguchi S, Hirasawa A, Tsujimoto G. Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach. Life Sci 2006, (in press)
   PubMed Web of Science ®Google Scholar
• Gauthier C, Langin D, Balligand JL. Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 2000; 21: 426–431
   PubMed Web of Science ®Google Scholar
• Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, Le Marec H. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 1998; 102: 1377–1384
   PubMed Web of Science ®Google Scholar
• Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest 1996; 98: 556–562
   PubMed Web of Science ®Google Scholar
• Gauthier C, Tavernier G, Trochu JN, Leblais V, Laurent K, Langin D, Escande D, Le Marec H. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther 1999; 290: 687–693
   PubMed Web of Science ®Google Scholar
• Goncalvesova E, Micutkova L, Mravec B, Ksinantova L, Krizanova O, Fabian J, Kvetnansky R. Changes in gene expression of phenylethanolamine N-methyltransferase in the transplanted human heart. Ann N Y Acad Sci 2004; 1018: 430–436
   PubMed Web of Science ®Google Scholar
• Granneman JG. The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor. Am J Physiol Endocrinol Metab 2001; 280: E199–E202
   Web of Science ®Google Scholar
• Gutstein DE, Marks AR. Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure. Heart Vessels 1997, Suppl 12: 53–57
   PubMedGoogle Scholar
• Hanson CJ, Bootman MD, Roderick HL. Cell signalling: IP3 receptors channel calcium into cell death. Curr Biol 2004; 14: R933–R935
   PubMed Web of Science ®Google Scholar
• Heubach JF, Rau T, Eschenhagen T, Ravens U, Kaumann AJ. Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol 2002; 136: 217–229
   PubMed Web of Science ®Google Scholar
• Huang MH, Bahl JJ, Wu Y, Hu F, Larson DF, Roeske WR, Ewy GA. Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. Am J Physiol Heart Circ Physiol 2005; 288: H497–H503
   Web of Science ®Google Scholar
• Huang MH, Friend DS, Sunday ME, Singh K, Haley K, Austen KF, Kelly RA, Smith TW. An intrinsic adrenergic system in mammalian heart. J Clin Invest 1996; 98: 1298–1303
   Google Scholar
• Jayaraman T, Marks AR. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 1997; 17: 3005–3012
   PubMed Web of Science ®Google Scholar
• Jeong J, Choi S, Gu C, Lee H, Park S. Genomic structure and promoter analysis of the mouse EphA8 receptor tyrosine kinase gene. DNA Cell Biol 2000; 19: 291–300
   PubMed Web of Science ®Google Scholar
• Jones OT, Kune DL, Angelides KJ. Localization and mobility of omega-conotoxin-sensitive Ca2+ channels in hippocampl CA1 neurons. Science 1989; 244: 1189–1193
   PubMed Web of Science ®Google Scholar
• Jurkovicova D, Kubovcakova L, Hudecova S, Kvetnansky R, Krizanova O. Adrenergic modulation of the type 1 IP3 receptors in the rat heart. Biochim Biophys Acta 2006; 1763: 18–24
   PubMed Web of Science ®Google Scholar
• Kaumann AJ, Molenaar P. Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 667–681
   PubMed Web of Science ®Google Scholar
• Kaumann AJ, Engelhardt S, Hein L, Molenaar P, Lohse M. Abolition of ( − )-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 87–93
   PubMed Web of Science ®Google Scholar
• Kenakin T. Principles: Receptor theory in pharmacology. Trends Pharmacol Sci 2004; 25: 186–192
   PubMed Web of Science ®Google Scholar
• Kennedy B, Ziegler MG. Cardiac epinephrine synthesis. Regulation by a glucocorticoid. Circulation 1991; 84: 891–895
   PubMed Web of Science ®Google Scholar
• Kennedy B, Ziegler MG. Ontogeny of epinephrine metabolic pathways in the rat: Role of glucocorticoids. Int J Dev Neurosci 2000; 18: 53–59
   PubMed Web of Science ®Google Scholar
• Kennedy B, Bigby TD, Ziegler MG. Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J Clin Invest 1995; 95: 2896–2902
   PubMed Web of Science ®Google Scholar
• Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM. Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res 2000; 87: 705–709
   PubMed Web of Science ®Google Scholar
• Krepsova K, Micutkova L, Novotova M, Kubovcakova L, Kvetnansky R, Krizanova O. Repeated immobilization stress decreases mRNA and protein levels of the type 1 IP3 receptor in rat heart. Ann N Y Acad Sci 2004; 1018: 339–344
   PubMed Web of Science ®Google Scholar
• Krizanova O, Kvetnansky R, Jurkovicova D. Effect of two distinct stressors on gene expression of the type 1 IP3 receptors. Gen Physiol Biophys 2005; 24: 237–246
   PubMed Web of Science ®Google Scholar
• Krizanova O, Micutkova L, Jelokova J, Filipenko M, Sabban E, Kvetnansky R. Existence of cardiac PNMT mRNA in adult rats: Elevation by stress in a glucocorticoid-dependent manner. Am J Physiol Heart Circ Physiol 2001; 281: H1372–H1379
   Web of Science ®Google Scholar
• Kvetnansky R, Kubovcakova L, Tillinger A, Micutkova L, Krizanova O, Sabban EL. Gene expression of phenylethanolamine n-methyltransferase in corticotropin-releasing hormone knockout mice during stress exposure. Cell Mol Neurobiol 2006, (in press)
   Web of Science ®Google Scholar
• Kvetnansky R, Micutkova L, Kubovcakova L, Sabban EL, Palkovits M, Krizanova O. Localization and regulation of phenylethanolamine N-methyltransferase gene expression in the heart of rats and mice during stress. Ann N Y Acad Sci 2004; 1018: 405–417
   PubMed Web of Science ®Google Scholar
• Kvetnansky R, Weise VK, Thoa NB, Kopin IJ. Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. J Pharmacol Exp Ther 1979; 209: 287–291
   PubMed Web of Science ®Google Scholar
• Lencesova L, Ondrias K, Micutkova L, Filipenko M, Kvetnansky R, Krizanova O. Immobilization stress elevates IP(3) receptor mRNA in adult rat hearts in a glucocorticoid-dependent manner. FEBS Lett 2002; 531: 432–436
   PubMed Web of Science ®Google Scholar
• Liang W, Austin S, Hoang Q, Fishman PH. Resistance of the human beta 1-adrenergic receptor to agonist-mediated down-regulation. Role of the C terminus in determining beta-subtype degradation. J Biol Chem 2003; 278: 39773–39781
   PubMed Web of Science ®Google Scholar
• Li P, Li J, Feng X, Hou R, Han C, Zhang Y. Gene expression profile of cardiomyocytes in hypertrophic heart induced by continuous norepinephrine infusion in the rats. Cell Mol Life Sci. 2003; 60: 2200–9
   PubMed Web of Science ®Google Scholar
• Li F, De Godoy M, Rattan S. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle. J Pharmacol Exp Ther 2004; 308: 1111–1120
   PubMed Web of Science ®Google Scholar
• Lipp P, Laine M, Tovey SC, Burrell KM, Berridge MJ, Li W, Bootman MD. Functional InsP3 receptors that may modulate excitation–contraction coupling in the heart. Curr Biol 2000; 10: 939–942
   PubMed Web of Science ®Google Scholar
• Mackenzie L, Bootman MD, Laine M, Berridge MJ, Thuring J, Holmes A, Li WH, Lipp P. The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 2002; 541: 395–409
   PubMed Web of Science ®Google Scholar
• Marks AR. Intracellular calcium-release channels: Regulators of cell life and death. Am J Physiol 1997; 272: H597–H605
   PubMed Web of Science ®Google Scholar
• Marks AR. Cardiac intracellular calcium release channels: Role in heart failure. Circ Res 2000; 87: 8–11
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Nagata E. Type 1 inositol 1,4,5-trisphosphate receptor knock-out mice: Their phenotypes and their meaning in neuroscience and clinical practice. J Mol Med 1999; 77: 406–411
   PubMed Web of Science ®Google Scholar
• Micutkova L, Krepsova K, Sabban E, Krizanova O, Kvetnansky R. Modulation of catecholamine-synthesizing enzymes in the rat heart by repeated immobilization stress. Ann N Y Acad Sci 2004; 1018: 424–429
   PubMed Web of Science ®Google Scholar
• Micutkova L, Kvetnansky R, Krizanova O. Repeated immobilization stress reduces the gene expression of the type 1 and 2 IP3 receptors in stellate ganglia. Neurochem Int 2003; 43: 557–561
   PubMed Web of Science ®Google Scholar
• Molenaar P, Sarsero D, Kaumann AJ. Proposal for the interaction of non-conventional partial agonists and catecholamines with the “putative beta 4-adrenoceptor” in mammalian heart. Clin Exp Pharmacol Physiol 1997; 24: 647–656
   PubMed Web of Science ®Google Scholar
• Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev 1999; 79: 1373–1430
   PubMed Web of Science ®Google Scholar
• Moschella MC, Marks AR. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J Cell Biol 1993; 120: 1137–1146
   PubMed Web of Science ®Google Scholar
• Muglia LJ, Jacobson L, Weninger SC, Karalis KP, Jeong K, Majzoub JA. The physiology of corticotropin-releasing hormone deficiency in mice. Peptides 2001; 22: 725–731
   PubMed Web of Science ®Google Scholar
• Myslivecek J, Novakova M, Palkovits M, Krizanova O, Kvetnansky R. Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart. Life Sci 2006; 79: 112–120
   PubMed Web of Science ®Google Scholar
• Myslivecek J, Ricny J, Kolar F, Tucek S. The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling. Naunyn Schmiedebergs Arch Pharmacol 2003; 368: 366–376
   PubMed Web of Science ®Google Scholar
• Myslivecek J, Ricny J, Palkovits M, Kvetnansky R. The effects of short-term immobilization stress on muscarinic receptors, beta-adrenoceptors, and adenylyl cyclase in different heart regions. Ann N Y Acad Sci 2004; 1018: 315–322
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hattori M, Uchida K, Nakamura T, Tateishi Y, Bannai H, Iwai M, Michikawa T, Inoue T, Mikoshiba K. The regulatory domain of the inositol 1,4,5-trisphosphate receptor is necessary to keep the channel domain closed: Possible physiological significance of specific cleavage by caspase 3. Biochem J 2004; 377: 299–307
   Google Scholar
• Pelat M, Verwaerde P, Galitzky J, Lafontan M, Berlan M, Senard JM, Montastruc JL. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs. J Pharmacol Exp Ther 2003; 304: 246–253
   PubMed Web of Science ®Google Scholar
• Perez PJ, Ramos-Franco J, Fill M, Mignery GA. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem 1997; 272: 23961–23969
   PubMed Web of Science ®Google Scholar
• Ponicke K, Schluter KD, Heinroth-Hoffmann I, Seyfarth T, Goldberg M, Osten B, Piper HM, Brodde OE. Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: Involvement of only alpha1A-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 444–453
   PubMed Web of Science ®Google Scholar
• Rowan RA, Billingham ME. Myocardial innervation in long-term heart transplant survivors: A quantitative ultrastructural survey. J Heart Transplant 1988; 7: 448–452
   PubMedGoogle Scholar
• Rozec B, Gauthier C. beta3-adrenoceptors in the cardiovascular system: Putative roles in human pathologies. Pharmacol Ther 2006; 111: 652–673
   PubMed Web of Science ®Google Scholar
• Sabban EL, Hiremagalur B, Nankova B, Kvetnansky R. Molecular biology of stress-elicited induction of catecholamine biosynthetic enzymes. Ann N Y Acad Sci 1995; 771: 327–338
   PubMed Web of Science ®Google Scholar
• Sabban EL, Nankova BB, Serova LI, Hiremagalur B, Rusnak M, Saez E, Spiegelman B, Kvetnansky R. Regulation of gene expression of catecholamine biosynthetic enzymes by stress. Adv Pharmacol 1998; 42: 564–567
   PubMedGoogle Scholar
• Santos IN, Spadari-Bratfisch RC. Chronotropic response to (+/ − )-CGP12177 in right atria of stressed rats. Can J Physiol Pharmacol 2001; 79: 393–399
   PubMed Web of Science ®Google Scholar
• Santos IN, Spadari-Bratfisch RC. Stress and cardiac beta adrenoceptors. Stress 2006; 9: 69–84
   PubMed Web of Science ®Google Scholar
• Santos IN, Sumitame M, Caceres VM, Moreira MF, Krieger MH, Spadari-Bratfisch RC. Evidence for two atypical conformations of beta-adrenoceptors and their interaction with Gi proteins. Eur J Pharmacol 2005; 513: 109–118
   PubMed Web of Science ®Google Scholar
• Schmid W, Cole TJ, Blendy JA, Schutz G. Molecular genetic analysis of glucocorticoid signalling in development. J Steroid Biochem Mol Biol 1995; 53: 33–35
   PubMed Web of Science ®Google Scholar
• Shah SD, Tse TF, Clutter WE, Cryer PE. The human sympathochromaffin system. Am J Physiol 1984; 247: E380–E384
   PubMed Web of Science ®Google Scholar
• Skeberdis VA. Structure and function of beta3-adrenergic receptors. Medicina (Kaunas) 2004; 40: 407–413
   PubMedGoogle Scholar
• Slavikova J, Dvorakova M, Reischig J, Palkovits M, Ondrias K, Tarabova B, Lacinova L, Kvetnansky R, Marks A, Krizanova O. IP3 type 1 receptors in the heart: Their predominance in atrial walls with ganglion cells. Life Sci 2006; 78: 1598–1602
   PubMed Web of Science ®Google Scholar
• Slavikova J, Kuncova J, Reischig J, Dvorakova M. Catecholaminergic neurons in the rat intrinsic cardiac nervous system. Neurochem Res 2003; 28: 593–598
   Google Scholar
• Tai TC, Claycomb R, Her S, Bloom AK, Wong DL. Glucocorticoid responsiveness of the rat phenylethanolamine N-methyltransferase gene. Mol Pharmacol 2002; 61: 1385–1392
   PubMed Web of Science ®Google Scholar
• Takahashi M, Taniguchi T, Kanamaru H, Okada K, Muramatsu I. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: Binding to recombinant human alpha1-adrenoceptors and human prostates. Life Sci 2000; 67: 2443–2451
   PubMed Web of Science ®Google Scholar
• Tavernier G, Toumaniantz G, Erfanian M, Heymann MF, Laurent K, Langin D, Gauthier C. beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res 2003; 59: 288–296
   PubMed Web of Science ®Google Scholar
• Teitelman G, Joh TH, Park D, Brodsky M, New M, Reis DJ. Expression of the adrenergic phenotype in cultured fetal adrenal medullary cells: Role of intrinsic and extrinsic factors. Dev Biol 1982; 89: 450–459
   PubMed Web of Science ®Google Scholar
• Thomas SA, Matsumoto AM, Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature 1995; 374: 643–646
   PubMed Web of Science ®Google Scholar
• Tillinger A, Bruderova V, Kubovcakova L, Zeman M, Kopacek J, Novakova M, Kvetnansky R, Krizanova O. Gene expression of the phenylethanolamine N-methyltransferase is differently modulated in cardiac atria and ventricles. Gen Physiol Biophys 2006a; 25: 355–364
   PubMed Web of Science ®Google Scholar
• Tillinger A, Novakova M, Pavlovicova M, Lacinova L, Zatovicova M, Pastorekova S, Krizanova O, Kvetnansky R. Modulation of gene expression of the PNMT in the heart during immobilization stress by 6-hydroxydopamine. Stress 2006b; 9: 207–213
   PubMed Web of Science ®Google Scholar
• Torda T, Culman J, Petrikova M. Distribution of phenylethanolamine-N-methyltransferase in the rat heart: Effect of 6-hydroxydopamine. Eur J Pharmacol 1987; 141: 305–308
   PubMed Web of Science ®Google Scholar
• Venihaki M, Majzoub J. Lessons from CRH knockout mice. Neuropeptides 2002; 36: 96–102
   PubMed Web of Science ®Google Scholar
• Wong DL, Anderson LJ, Tai TC. Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression. Ann N Y Acad Sci 2002; 971: 19–26
   PubMed Web of Science ®Google Scholar
• Wong DL, Siddall BJ, Ebert SN, Bell RA, Her S. Phenylethanolamine N-methyltransferase gene expression: Synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor. Brain Res Mol Brain Res 1998; 61: 154–161
   PubMedGoogle Scholar
• Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q. Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 2006; 27: 330–337
   PubMed Web of Science ®Google Scholar
• Xu Y, Menon V, Jugdutt BI. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins. J Renin Angiotensin Aldosterone Syst 2000; 1: 184–195
   PubMedGoogle Scholar
• Yamada J, Ohkusa T, Nao T, Ueyama T, Yano M, Kobayashi S, Hamano K, Esato K, Matsuzaki M. Up-regulation of inositol 1,4, 5-trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J Cardiol 2002; 39: 57–58
   PubMedGoogle Scholar
• Zacikova L, Ondrias K, Kvetnansky R, Krizanova O. Identification of type 1 IP(3) receptors in the rat kidney and their modulation by immobilization stress. Biochim Biophys Acta 2000; 1466: 16–22
   PubMed Web of Science ®Google Scholar
• Zheng M, Han QD, Xiao RP. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance. Sheng Li Xue Bao 2004; 56: 1–15
   PubMedGoogle Scholar
• Zhou QY, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 1995; 374: 640–643
   PubMed Web of Science ®Google Scholar
• Zimmer HG. Catecholamine-induced cardiac hypertrophy: Significance of proto-oncogene expression. J Mol Med 1997; 75: 849–859
   PubMed Web of Science ®Google Scholar